BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 18637944)

  • 21. Identification of critical IgG binding epitopes on the neonatal Fc receptor.
    Vaughn DE; Milburn CM; Penny DM; Martin WL; Johnson JL; Bjorkman PJ
    J Mol Biol; 1997 Dec; 274(4):597-607. PubMed ID: 9417938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodies.
    Sand KM; Dalhus B; Christianson GJ; Bern M; Foss S; Cameron J; Sleep D; Bjørås M; Roopenian DC; Sandlie I; Andersen JT
    J Biol Chem; 2014 Jun; 289(24):17228-39. PubMed ID: 24764301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand.
    Sánchez LM; Penny DM; Bjorkman PJ
    Biochemistry; 1999 Jul; 38(29):9471-6. PubMed ID: 10413524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse MHC class I-like Fc receptor encoded outside the MHC.
    Ahouse JJ; Hagerman CL; Mittal P; Gilbert DJ; Copeland NG; Jenkins NA; Simister NE
    J Immunol; 1993 Dec; 151(11):6076-88. PubMed ID: 7504013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.
    Burmeister WP; Gastinel LN; Simister NE; Blum ML; Bjorkman PJ
    Nature; 1994 Nov; 372(6504):336-43. PubMed ID: 7969491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fc engineering: serum half-life modulation through FcRn binding.
    Olafsen T
    Methods Mol Biol; 2012; 907():537-56. PubMed ID: 22907373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta.
    Simister NE; Story CM; Chen HL; Hunt JS
    Eur J Immunol; 1996 Jul; 26(7):1527-31. PubMed ID: 8766556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization.
    Vaughn DE; Bjorkman PJ
    Biochemistry; 1997 Aug; 36(31):9374-80. PubMed ID: 9235980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and characterization of recombinant single-chain salmon class I MHC fused with beta2-microglobulin with biological activity.
    Zhao H; Stet RJ; Skjødt K; Savelkoul HF
    Fish Shellfish Immunol; 2008 Apr; 24(4):459-66. PubMed ID: 18280180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FcRn mediates elongated serum half-life of human IgG in cattle.
    Kacskovics I; Kis Z; Mayer B; West AP; Tiangco NE; Tilahun M; Cervenak L; Bjorkman PJ; Goldsby RA; Szenci O; Hammarström L
    Int Immunol; 2006 Apr; 18(4):525-36. PubMed ID: 16481343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies.
    Wang W; Vlasak J; Li Y; Pristatsky P; Fang Y; Pittman T; Roman J; Wang Y; Prueksaritanont T; Ionescu R
    Mol Immunol; 2011 Mar; 48(6-7):860-6. PubMed ID: 21256596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction.
    Mezo AR; McDonnell KA; Castro A; Fraley C
    Bioorg Med Chem; 2008 Jun; 16(12):6394-405. PubMed ID: 18501614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple roles for the major histocompatibility complex class I- related receptor FcRn.
    Ghetie V; Ward ES
    Annu Rev Immunol; 2000; 18():739-66. PubMed ID: 10837074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,).
    West AP; Bjorkman PJ
    Biochemistry; 2000 Aug; 39(32):9698-708. PubMed ID: 10933786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and applications of AlphaScreen-based FcRn binding assay to characterize monoclonal antibodies.
    Wu Q; Lee HY; Wong PY; Jiang G; Gazzano-Santoro H
    J Immunol Methods; 2015 May; 420():31-7. PubMed ID: 25837414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of new models for the analysis of Fc-FcRn interactions.
    Gurbaxani BM; Morrison SL
    Mol Immunol; 2006 Mar; 43(9):1379-89. PubMed ID: 16183124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of the gene encoding the bovine neonatal Fc receptor.
    Doleschall M; Zhao Y; Mayer B; Hammarström L; Kacskovics I
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):145-50. PubMed ID: 16095719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn
    Mester S; Evers M; Meyer S; Nilsen J; Greiff V; Sandlie I; Leusen J; Andersen JT
    MAbs; 2021; 13(1):1893888. PubMed ID: 33691596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal Fc Receptor Binding Tolerance toward the Covalent Conjugation of Payloads to Cysteine 34 of Human Albumin Variants.
    Petersen SS; Kläning E; Ebbesen MF; Andersen B; Cameron J; Sørensen ES; Howard KA
    Mol Pharm; 2016 Feb; 13(2):677-82. PubMed ID: 26654692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.
    Grevys A; Bern M; Foss S; Bratlie DB; Moen A; Gunnarsen KS; Aase A; Michaelsen TE; Sandlie I; Andersen JT
    J Immunol; 2015 Jun; 194(11):5497-508. PubMed ID: 25904551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.